Author:
Nilsson Sten,Franzén Lars,Parker Christopher,Tyrrell Christopher,Blom René,Tennvall Jan,Lennernäs Bo,Petersson Ulf,Johannessen Dag C,Sokal Michael,Pigott Katharine,Yachnin Jeffrey,Garkavij Michael,Strang Peter,Harmenberg Johan,Bolstad Bjørg,Bruland Øyvind S
Reference15 articles.
1. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer;Saad;J Natl Cancer Inst,2004
2. Radioisotopes for the palliation of metastatic bone cancer: a systematic review;Finlay;Lancet Oncol,2005
3. Bone-seeking radionuclides for therapy;Lewington;J Nucl Med,2005
4. Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice;Henriksen;J Nucl Med,2003
5. Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model;Henriksen;Cancer Res,2002
Cited by
444 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献